Published: Fri, May 18, 2018
Economy | By

Northgate plc (LON:NTG) Analyst Ratings as of May 14, 2018

Northgate plc (LON:NTG) Analyst Ratings as of May 14, 2018

About 353,892 shares traded. J Sainsbury plc (LON:SBRY) has 0.00% since May 15, 2017 and is. NICL underperformed the S&P 500 by 11.55%.

Among 2 analysts covering Peoples Operator Plc (LON:TPOP), 2 have Buy rating, 0 Sell and 0 Hold.

LWB reached GBX 55.3 during the last trading session after GBX 0.3 change.Currently Low & Bonar PLC is after 0.00% change in last May 14, 2017. GBX 20's average target is 80221.29% above currents GBX 0.0249 stock price. TalkTalk Telecom Group PLC had 168 analyst reports since July 23, 2015 according to SRatingsIntel. Liberum Capital reaffirmed a "buy" rating and set a GBX 2,360 ($32.01) price objective on shares of Ashtead Group in a research report on Tuesday, March 6th. Liberum Capital maintained the shares of TW in report on Friday, September 23 with "Hold" rating. The firm has "Neutral" rating given on Thursday, October 22 by Nomura. The rating was maintained by Peel Hunt on Friday, December 15 with "Buy". The company rating was maintained by Berenberg on Wednesday, March 14. Karpus holds 0.65% or 721,448 shares. The firm has "Overweight" rating given on Thursday, July 30 by Barclays Capital. On Friday, January 5 the stock has "Hold" rating by Numis Securities. Jefferies has "Buy" rating and GBX 1700 target. Therefore 14% are positive. The firm earned "Market Perform" rating on Monday, January 25 by Bernstein. The firm has "Corporate" rating by FinnCap given on Monday, April 18. On Thursday, January 7 the stock rating was maintained by RBC Capital Markets with "Outperform". The stock has "Neutral" rating by JP Morgan on Monday, March 12. (NYSE:GES) has "Hold" rating given on Thursday, August 24 by Jefferies. Peel Hunt reissued a "hold" rating on shares of Entertainment One in a research note on Wednesday, April 4th. The stock has "Overweight" rating by JP Morgan on Friday, May 11.

Medtronic plc manufactures and sells device medical therapies to hospitals, physicians, clinicians, and patients worldwide. The company has market cap of $138.72 million. The BioStim segment makes, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion and are indicated as treatment to improve fusion success rates in cervical and lumbar spine, as well as a therapeutic treatment for non-spine fractures. The firm offers virtual office services; 24/7 workspace recovery solutions; mobile and digital self-service solutions; co-working solutions; fully managed offices; networking and knowledge-sharing meetings; and meeting spaces and workshops.The P/E ratio is 24.98. It also provides transcatheter heart valves, percutaneous coronary intervention stents, surgical valve replacement and fix products, endovascular stent grafts, peripheral vascular products, and products to treat superficial and deep venous diseases.

Like this: